Adapalene And Benzoyl Peroxide Gel
NDC Package 51672-1364-3
Package Information
Adapalene And Benzoyl Peroxide gel is 0.1%/2.5% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. This formulation utilizes a gel delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-1364 and is authorized under FDA application ANDA206959.
Identification & Billing
- RxCUI: 829539 - adapalene 0.1 % / benzoyl peroxide 2.5 % Topical Gel
- RxCUI: 829539 - adapalene 0.001 MG/MG / benzoyl peroxide 0.025 MG/MG Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-1364 - Adapalene And Benzoyl Peroxide
- 51672-1364-3 - 1 BOTTLE, PUMP in 1 CARTON / 45 g in 1 BOTTLE, PUMP
- 51672-1364 - Adapalene And Benzoyl Peroxide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-1364). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-1364-3 identifies a specific commercial package of 1 bottle, pump in 1 carton / 45 g in 1 bottle, pump of Adapalene And Benzoyl Peroxide, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This gel is formulated for topical use and contains adapalene; benzoyl peroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on January 24, 2018. The current certification is valid through December 31, 2026.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672136403. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.